Search
Returning search results with filters:
Remove filter for
Category: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 271 - 285 of 462 items.
Clinical management support: Known interference between Hemlibra® (emicizumab injection) and lab assays used to diagnose coagulopathy / DIC caused by COVID-19 infection
AlertHealth professional risk communication | 2020-04-17
Shortage of salbutamol inhalers in Canada
AlertPublic advisory | 2020-04-17
Fraudulent and unauthorized N95 respirators may not protect consumers against COVID-19
AlertPublic advisory | 2020-04-14
Homemade hand sanitizers may present health risks
AlertPublic advisory | 2020-04-02
Methadone Treatment of Opioid Dependence and Potential Differences in Product Effect
AlertHealth professional risk communication | 2020-03-31
Stockpiling drugs can lead to local shortages: Canadians urged not to buy more medication than usual during the COVID-19 pandemic
AlertPublic advisory | 2020-03-30
Health products that make false or misleading claims to prevent, treat or cure COVID-19 may put your health at risk
AlertPublic advisory | 2020-03-27
No scientific evidence that ibuprofen worsens COVID-19 symptoms
AlertInformation update | 2020-03-20
Unauthorized skin lightening product seized from Danforth Variety & Fruit Market: Product may pose serious health risks
AlertPublic advisory | 2020-03-19
Update on the rifampin drug shortage
AlertPublic advisory | 2020-03-15
Unauthorized products may pose serious health risks (February 10, 2020 to March 13, 2020)
AlertPublic advisory | 2020-03-13
Cybersecurity vulnerabilities associated with some medical devices with Bluetooth Low Energy chips
AlertInformation update | 2020-03-11